Novaremed AG
About:
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Website: http://www.novaremed.com/
Top Investors: The Global Emerging Markets Group
Description:
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Total Funding Amount:
$52.6M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Basel, Basel-Stadt, Switzerland
Founded Date:
2017-01-01
Founders:
Eli Kaplan
Number of Employees:
1-10
Last Funding Date:
2021-02-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai